Read all diagnostic and biotech reports at http://www.alliedmarketresearch.com/diagnostic-and-biotech-market-report-5
This report segments the global diagnostic biomarker on the basis of diagnostic biomarker types, applications and service. Applications market further segments as risk assessment, molecular diagnostics, disease diagnosis, drug discovery and development, drug formulation, forensic applications and others. The report particularly focuses on biomarkers for diagnostic applications and excludes clinical trials and research.
Related market studies by Allied Market Research
Noninvasive Cancer Diagnostics and Technologies Market http://www.alliedmarketresearch.com/noninvasive-cancer-diagnostics-market=70
Medical Implants Market http://www.alliedmarketresearch.com/medical-implants-market=71
Histone Deacetylase Inhibitors Market http://www.alliedmarketresearch.com/histone-deacetylase-inhibitors-market=61
With respect to geography, Asia Pacific is expected to have the highest CAGR at 20.3% from 2013 to 2020. Companies profiled in this report include Roche Diagnostic Limited (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Aushon BioSystem Inc. (U.S.), Epistem Ltd. (U.K.), G.E. Healthc
|SOURCE Allied Market Research|
Copyright©2012 PR Newswire.
All rights reserved